A new targeted drug has a good safety profile and has led to responses in some patients with particular genetic characteristics in their tumours.

A cutting-edge form of non-invasive imaging technology can track the response of malignant melanoma cells to treatment, researchers have found.

Transport links in Sutton, and the potential for science to drive economic growth, were two of the themes of a visit by Government minister Lord Prior to The London Cancer Hub.